Nexsen Ltd

Nexsen Limited is an Australia-based nanobiotechnology company. The Company is focused on development of proprietary biosensing platforms for rapid, high precision point-of-care (POC) medical diagnostics and point-of-use sensing for veterinary, agricultural and biosecurity applications. Its product pipeline includes GBS Rapid Sensor, Chronic kidney disease, and bovine mastitis. Its lead product, the GBS Rapid Sensor, is a diagnostic for the detection of human Group B Streptococcus (GBS) in expectant mothers. The Company is also developing a paper-based chronic kidney disease (CKD) test designed for early detection and routine monitoring across both clinics and at-home use. The bovine mastitis test is designed to test bovine mastitis in cows.